Trademark: 97675763
Word
XENOIMMUNE
Status
Pending
Status Code
730
Status Date
Tuesday, September 3, 2024
Serial Number
97675763
Mark Type
4
Filing Date
Monday, November 14, 2022
Published for Opposition
Tuesday, January 9, 2024

Trademark Owner History
Lapix Therapeutics, Inc. - Owner At Publication

Classifications
44 Providing antibody titration testing services to predict the human response to antigens for medical purposes
31 Live testing animals used to predict the human response to antigens
42 Providing serological, cytokines, and immunophenotyping testing services to predict the human response to antigens for scientific purposes

Trademark Events
Sep 1, 2023
Non-Final Action E-Mailed
Nov 17, 2022
New Application Entered
Dec 5, 2022
New Application Office Supplied Data Entered
Aug 28, 2023
Assigned To Examiner
Sep 1, 2023
Non-Final Action Written
Sep 25, 2023
Teas Change Of Correspondence Received
Sep 1, 2023
Notification Of Non-Final Action E-Mailed
Sep 25, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 25, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 1, 2023
Teas Response To Office Action Received
Dec 1, 2023
Correspondence Received In Law Office
Dec 1, 2023
Teas/Email Correspondence Entered
Dec 6, 2023
Approved For Pub - Principal Register
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Jan 9, 2024
Published For Opposition
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 3, 2024
Sou Teas Extension Received
Sep 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 3, 2024
Sou Extension 1 Granted
Sep 3, 2024
Sou Extension 1 Filed
Mar 5, 2024
Noa E-Mailed - Sou Required From Applicant

Trademark Alertz updated from USPTO on 2030-01-24